In a pregnant woman with a normal oral glucose tolerance test (OGTT) at 23 weeks gestation, is a repeat OGTT required between 24 and 28 weeks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Repeat OGTT Needed

A normal OGTT at 23 weeks does not require routine repeat testing between 24-28 weeks in the same pregnancy. The standard screening window is 24-28 weeks gestation, and your test at 23 weeks falls within the acceptable timeframe and fulfills the screening requirement 1, 2, 1.

Why No Repeat is Necessary

The major clinical practice guidelines consistently recommend a single OGTT performed between 24-28 weeks gestation for gestational diabetes screening 1, 2, 3, 4. Your test at 23 weeks is:

  • Within one week of the recommended window - This minor timing difference has no clinical significance
  • Already completed the screening requirement - The 24-28 week recommendation is a range, not a strict mandate
  • Normal result is valid - There is no evidence supporting routine repeat testing after a normal OGTT in this timeframe

The Evidence Behind Timing

The Endocrine Society and American Diabetes Association guidelines specify testing at "24 to 28 weeks gestation" based on the HAPO study, which demonstrated that maternal glucose levels at this gestational age correlate with adverse outcomes 1, 2, 4. The one-week difference between 23 and 24 weeks is not clinically meaningful - the physiologic changes of pregnancy that unmask gestational diabetes are already present.

Important Caveats

You would need repeat testing only if:

  • New risk factors emerge (significant weight gain, polyhydramnios, fetal macrosomia on ultrasound, new glucosuria)
  • Clinical symptoms of hyperglycemia develop
  • You had borderline values on the 23-week test (just below diagnostic thresholds)

Common Pitfall to Avoid

Some providers mistakenly believe that testing before exactly 24 weeks requires automatic repeat testing. This leads to unnecessary patient burden and healthcare costs without evidence of benefit. The 24-28 week window represents optimal timing, but testing at 23 weeks captures the same pathophysiology 5.

Bottom line: Your normal OGTT at 23 weeks completes your gestational diabetes screening for this pregnancy. Proceed with routine prenatal care unless new concerning features develop 1.

Related Questions

What glucose load (grams) and gestational age are recommended for performing an oral glucose tolerance test (OGTT) in pregnancy?
With a 2‑hour oral glucose tolerance test result of 165 mg/dL at 28 weeks gestation, is a repeat test required?
Is a 156 mg/dL oral glucose tolerance test result at 28 weeks gestation diagnostic for gestational diabetes, and what is the recommended management?
In an 85-year-old patient with sweating and feeling hot (hot flashes), what are the likely causes and how should it be evaluated?
Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
Is gentamicin appropriate for treating a urinary tract infection caused by methicillin‑resistant Staphylococcus aureus (MRSA) when the isolate is susceptible?
What does pruning of the pulmonary arteries on imaging indicate, and how should it be evaluated and managed for possible pulmonary hypertension?
At what age does the American Academy of Pediatrics recommend initiating blood pressure measurements at routine well-child visits?
Given a normal liver ultrasound and liver function tests (GGT 9 U/L, AST 22 U/L, ALT 15 U/L) with a mildly elevated mean corpuscular volume (MCV 97.3 fL) and mean corpuscular hemoglobin (MCH 33.6 pg), does this indicate any liver disease or require further evaluation?
Is hidradenitis suppurativa associated with celiac disease?
What electrolyte imbalances can occur with linezolid therapy and how should they be monitored and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.